Alexandre Thibonnier

Alexandre Thibonnier, M.Eng MBA, has a diverse and extensive work experience in the pharmaceutical and biotechnology industry. Starting in 2008 as an MBA Intern at Genzyme, they have held various roles in market insights and competitive intelligence at Shire, Takeda, and Novartis. Thibonnier has also worked as a Senior Manager and Manager at Sunovion Pharmaceuticals, where they focused on portfolio analysis and commercial insights. Additionally, they have experience in corporate strategic planning and development from their time at Boston Scientific and Vertex Pharmaceuticals. Thibonnier holds a Master of Engineering degree and an MBA. Currently, they serve as the Director of New Product Planning and Global Commercial Strategy at Deciphera Pharmaceuticals.

Alexandre Thibonnier, M.Eng MBA, has a strong education background in both engineering and business. Alexandre holds a Master of Engineering degree in Pharmaceutical Engineering from the University of Michigan, as well as a Bachelor of Science in Chemical Engineering from the same institution. Alexandre also completed their MBA with a focus on Health Sector Management and Entrepreneurship at the Questrom School of Business, Boston University. Alexandre furthered their education through executive education programs at The Wharton School, where they studied Strategy and Management for Competitive Advantage, as well as Mergers & Acquisitions. In addition to their formal education, Alexandre has obtained various certifications, including Microsoft Project 2019 and Project Online Desktop Essential Training, Mergers & Acquisitions, Strategic Partnerships, and they are a certified Competitive Intelligence Professional by the SCIP (Strategic and Competitive Intelligence Professionals).